← Leaderboards
James Even Voss
Scripps Research Institute, The
$6,757,823
Attributed
$8,636,578
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,156,413 · 6
By mechanism
R01$7,452,622 · 2
P01$4,215,666 · 3
R21$488,125 · 1
Top collaborators
- Adi Barzel4 shared
- Paula M Cannon4 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Paula M Cannon$25,669,125
- Charles Daniel Murin$2,541,934
- Kenneth Michael Pollard$20,670,399
- Raiees Ahmad Andrabi$11,723,355
- Adi Barzel$939,377
Others in their field
Other Emerging Leaders on “Neutralizing Antibody”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Yunda Huang · Fred Hutchinson Cancer Center$61,361,891
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Wilton B Williams · Duke University$19,801,567
- Priyamvada Acharya · Duke University$12,946,066
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$12,579,390
Research focus
Neutralizing AntibodyB-LymphocytesVaccinationCellsAffinityGenome EditingEngineeringInfectionAntibodiesViremiaGenesIn VivoResponseAntigensAnimal ModelB-Cell Antigen ReceptorCellular EngineeringMemoryVirusImmunocompetentImmune SystemAnimalsDesignImmunoglobulins
Grant awards (15)
PlanB2CureHIV (the 'PlanB' consortium)$3,519,835
P01 · FY2025 · HL · contact PI
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells$857,707
R01 · FY2025 · AI · contact PI
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies$700,174
R01 · FY2025 · AI · contact PI
in vivo modeling of IgH-reprogrammed B cells in mice$647,573
P01 · FY2025 · HL · contact PI
Administrative Core$48,258
P01 · FY2025 · HL · contact PI
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells$866,189
R01 · FY2024 · AI · contact PI
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies$733,631
R01 · FY2024 · AI · contact PI
Characterization of iGL-VRC01 Memory B cell Responses in Mice$150,000
R01 · FY2024 · AI · contact PI
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells$1,039,249
R01 · FY2023 · AI · contact PI
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies$738,581
R01 · FY2023 · AI · contact PI
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells$835,484
R01 · FY2022 · AI · contact PI
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies$645,746
R01 · FY2022 · AI · contact PI
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells$885,861
R01 · FY2021 · AI · contact PI
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform$221,875
R21 · FY2021 · AI · contact PI
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform$266,250
R21 · FY2020 · AI · contact PI